Gregucci Fabiana, Bonzano Elisabetta, Ng John, Talebi Fereshteh, Patel Maahi, Trick Dakota, Chandrasekhar Sharanya, Zhou Xi Kathy, Fenton-Kerimian Maria, Pennell Ryan, Formenti Silvia C
Department of Radiation Oncology, Weill Cornell Medicine, New York, NY 10065, USA.
Department of Radiation Oncology, IRCCS San Matteo Polyclinic Foundation, 27100 Pavia, Italy.
Cancers (Basel). 2025 May 3;17(9):1562. doi: 10.3390/cancers17091562.
Prone breast radiotherapy has been shown to optimally spare the dose to the heart and lungs; we report on the heart and left anterior descending coronary artery (LAD) dosimetry and their implications for current care. : (I) To measure the mean heart dose (MHD) and LAD mean and maximum doses (Dmean and Dmax) in patients with left-side breast cancer who have undergone hypo-fractionated whole breast radiotherapy (WBRT) with a concomitant boost to the post-operative cavity (40.50 Gy to the breast and 48 Gy to the cavity in 15 fractions) in the prone position; (II) to compare the dosimetry results to those reported in the literature for other techniques. In a consecutive series of 524 irradiated left-side breast cancer patients, heart and LAD dosimetry data were collected and correlated to breast volume and the volume of the radiation boost to the tumor cavity. A descriptive statistical analysis was performed to compare the same dosimetry data with those reported in the literature from supine techniques. To account for dosimetry differences in hypo-fractionation and conventional fractionated regimens (50-60 Gy in 25-30 fractions) reported in the literature, the cardiac doses were converted to the equivalent dose in 2 Gy fractions (EQD2). As previously reported, the prone setup protocol placed the medial edges of the tangential radiation fields at least 2.5 mm from the contoured LAD. In all patients' plans, the target coverage was successfully achieved. The mean values (±SD) were as follows: MHD = 0.69 Gy (±0.19) (EQD2 0.35 Gy ± 0.1); LAD Dmean = 2.20 Gy (±0.68) (EQD2 1.18 Gy ± 0.35); LAD Dmax = 4.44 Gy (±1.82) (EQD2 2.55 Gy ± 0.97). The values were consistently lower compared with those achieved by the multiple supine techniques reported in the literature. Spearman's correlation analysis revealed a strong positive correlation between LAD and heart dosimetry variables. In contrast, no strong correlation was observed between the cardiac dose metrics and breast volume, boost volume, or their ratio index. A linear correlation was detected between LAD Dmean and LAD D2% (R 0.64); LAD D2% and heart D2% (R 0.60); LAD Dmax and heart D2% (R 0.41). The prone position protocol minimizes heart and LAD exposure. This approach results in a dosimetry advantage when compared with more complex and expensive WBRT techniques in the supine position.
俯卧位乳腺癌放疗已被证明能最佳地减少心脏和肺部的受量;我们报告心脏和左前降支冠状动脉(LAD)的剂量测定及其对当前治疗的影响。:(I)测量左侧乳腺癌患者在俯卧位接受大分割全乳放疗(WBRT)并同步加量照射术后瘤腔(15次分割,乳腺剂量40.50 Gy,瘤腔剂量48 Gy)时的平均心脏剂量(MHD)以及LAD的平均剂量和最大剂量(Dmean和Dmax);(II)将剂量测定结果与文献中报道的其他技术的结果进行比较。在连续的524例接受放疗的左侧乳腺癌患者中,收集心脏和LAD的剂量测定数据,并将其与乳腺体积以及瘤腔加量照射的体积相关联。进行描述性统计分析,以将相同的剂量测定数据与文献中仰卧位技术报道的数据进行比较。为了考虑文献中报道的大分割和常规分割方案(25 - 30次分割,50 - 60 Gy)中的剂量测定差异,将心脏剂量转换为2 Gy分割的等效剂量(EQD2)。如先前报道,俯卧位设置方案使切线野的内侧边缘距离勾勒出的LAD至少2.5 mm。在所有患者的计划中,均成功实现了靶区覆盖。平均值(±标准差)如下:MHD = 0.69 Gy(±0.19)(EQD2 0.35 Gy ± 0.1);LAD Dmean = 2.20 Gy(±0.68)(EQD2 1.18 Gy ± 0.35);LAD Dmax = 4.44 Gy(±1.82)(EQD2 2.55 Gy ± 0.97)。与文献中报道的多种仰卧位技术所获得的值相比,这些值始终较低。Spearman相关性分析显示LAD和心脏剂量测定变量之间存在强正相关。相比之下,未观察到心脏剂量指标与乳腺体积、加量体积或它们的比值指数之间有强相关性。检测到LAD Dmean与LAD D2%之间存在线性相关性(R = 0.64);LAD D2%与心脏D2%之间(R = 0.60);LAD Dmax与心脏D2%之间(R = 0.41)。俯卧位方案可将心脏和LAD的受照剂量降至最低。与仰卧位更复杂且昂贵的WBRT技术相比,这种方法在剂量测定方面具有优势。